Navigation Links
Rebuilding the evolutionary history of HIV-1 unravels a complex loop
Date:11/23/2007

An essential component of the human immunodeficiency virus (HIV-1) molecular machinery responsible for infecting cells consists of functionally-specialized layers, according to a study by investigators at the University of California San Diego (UCSD) Antiviral Research Center (AVRC), published November 23 in PLoS Computational Biology.

The unprecedented genetic diversity and adaptability of HIV-1 has so far foiled the best efforts to eradicate the global HIV/AIDS epidemic. The surface of the HIV-1 particle is studded with protein spikes that allow the virus to enter human cells. This study examined an important component of the protein spike called the third variable loop (labeled V3).

Protein components like V3 are problematic because they are so diverse; up to 35% of the amino acids can differ between strains of HIV-1. Exposed to human antibodies, V3 rapidly evolves to avoid the immune system. However, the V3 loops critical function as a docking mechanism for HIV-1 to infect cells must impose limits on these evolutionary contortions. By deciphering the hidden limits on HIV-1 evolution, scientists hope to facilitate the development of antiviral drugs and vaccines.

The investigators developed a new method combining techniques from molecular evolution and artificial intelligence. They reconstructed the evolutionary history underlying 1,145 genetic sequences encoding the V3 loop to discover groups of amino acids that were biologically dependent on each other. These co-evolving amino acids formed ties across the V3 loop like rungs on a ladder, corroborating models from structural studies of the same protein.

The investigators caution that this study was restricted to a small portion of the genome. Nevertheless, the study represents a significant advancement in our understanding of HIV-1 evolution and identifies important targets in the protein spike for future research.


'/>"/>

Contact: Mary Kohut
Press@plos.org
415-568-3460
Public Library of Science
Source:Eurekalert

Page: 1

Related biology news :

1. Clones on task serve greater good, evolutionary study shows
2. Adaptation to parasites drive African fishes along different evolutionary paths
3. Old developmental pathways spawn revolutionary evolutionary changes
4. New study sheds light on Galápagos hawk evolutionary history
5. A new explanation for evolutionary changes in genetic sex-determination systems
6. Predators and parasites may increase evolutionary stability
7. Time-sharing tropical birds key to evolutionary mystery
8. Evolutionary biology research on plant shows significance of maternal effects
9. Evolutionary comparison finds new human genes
10. Satellites witness lowest Arctic ice coverage in history
11. Census of protein architectures offers new view of history of life
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... , June 30, 2015 Genisphere ... as CEO to help further develop Genisphere,s therapeutics capabilities ... partnering experience, having spent much of the last 25 ... Amgen, Baxter Bioscience, and Johnson & Johnson. Tom started ... Technology and Biotech Corporate Finance. He graduated from Dartmouth ...
(Date:6/25/2015)... June 25, 2015 According ... Type (Swipe & Area), Technology, Material (Optical Prism, ... Commercial Security & Others) & Geography - Global ... the said market is expected to reach $14,500.07 ... Browse 76 market Tables and ...
(Date:6/24/2015)... 2015 The biologics safety testing market is ... the market include growth of the pharmaceutical and biological ... Over the years, the number of drug approvals in ... the FDA approved 225 drug applications and Health Canada ... Europe accounted for 3,822 of the pharmaceutical ...
Breaking Biology News(10 mins):Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4
... from deciphering the human genetic code has acted as ... vital in the identification of genes associated with disease ... genetic therapies to treat a wide range of inherited ... diagnoses, greatly improved prevention and treatment of diseases and ...
... be more widespread in the animal kingdom than previously ... some male fiddler crabs "lie" about their fighting ability ... are in fact weak and puny. Published this week ... , the study is the first direct evidence that ...
... and his team are researching nano-scale cantilevers that have the ... gases in the air. Put them into a small handheld ... in battle, in industry, in health care and even at ... do this work has been something we,ve only seen so ...
Cached Biology News:Personalized medicine: Innovative online journal leads the way 2Fiddler crabs reveal honesty is not always the best policy 2Fiddler crabs reveal honesty is not always the best policy 3Clemson researchers advance nano-scale electromechanical sensors 2
(Date:7/28/2015)... ... , ... VetStem Biopharma will be offering weekly private guided tours of our ... , The tour and course will be given every Wednesday at 6pm to local ... Staff members are welcome to attend with their veterinarian as well. Participants will be ...
(Date:7/28/2015)... July 28, 2015 Tauriga Sciences, Inc. (OTCQB:  ... sciences company, today announced that its stockholders approved an ... stock of the Company from 1,000,000,000 to 2,500,000,000 at ... 2015 at the Law Offices of Nixon Peabody LLP ... Meeting, there were 480,655,929 shares of common stock represented ...
(Date:7/28/2015)... 2015  Moerae Matrix Inc. announced today the ... with MMI-0100, a first-in-class inhibitor of MAPKAP kinase ... disorders characterized by inflammation and fibrosis.  The study, ... , is a double-blind, two-way cross-over design lipopolysaccharide ... tolerability of MMI-0100 when given via inhalation to ...
(Date:7/28/2015)... July 28, 2015 CSL Behring ... has accepted for review the company,s Biologics License Application ... (rVIII-SingleChain) for the treatment of hemophilia A. In the ... Hemophilia A is a congenital ... nearly all affected patients are male. People with hemophilia ...
Breaking Biology Technology:VetStem Biopharma weekly veterinary continuing education classes and GMP manufacturing facility tour 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 3Moerae Initiates Lipopolysaccharide (LPS) Challenge Study of Inhaled MMI-0100 for Pulmonary Disease Following Encouraging Safety and Tolerability Observed in Single Ascending Dose Phase 1 Study 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 3
... we will use our mobile phone to buy bus and ... other European states by just presenting an electronic card or ... Most of us hate standing in queues or filling ... signatures could save hours of our time running to offices ...
... Ruedi Waeger , Ph.D., former president and CEO of Aventis ... with the Robert W. Reilly Leadership award June 15 at the ... , , ... (PPTA) and recognizes individuals who exemplify the leadership qualities of Robert Reilly ...
... FLEMINGTON, N.J. , June 24 Beardsworth Consulting Group, ... the company,s Scientific Advisor, Oncology and Robert W. Malone , M.D. ... , , ... respected research leaders with over 20 years of clinical research experience.  She ...
Cached Biology Technology:Really smart card project scoops EUREKA 2010 Innovation Award 2Really smart card project scoops EUREKA 2010 Innovation Award 3Really smart card project scoops EUREKA 2010 Innovation Award 4Ruedi Waeger Receives the 2010 Robert W. Reilly Leadership Award from Plasma Protein Therapeutics Association 2Alison Martin, MD and Robert W. Malone, MD Join Beardsworth 2
... ANTI-RNase is a protein ribonuclease inhibitor that noncovalently ... No inhibition is seen with RNase 1, T1, ... distinct from human placental ribonuclease inhibitor in that ... and does not release active RNase in the ...
... Ribonuclease Inhibitor is a recombinant protein that ... of RNA in the preparation of cDNA by ... in vitro protein synthesis. RNA Safe Inhibitor tightly ... a broad range of eukaryotic RNases such as ...
... Natural and Recombinant RNasin Ribonuclease Inhibitors ... the inhibition of eukaryotic RNases of the ... its inhibitory effect by noncovalently binding to ... value for the binding of RNasin Ribonuclease ...
...
Biology Products: